Acne severity and the Global Acne Grading System in polycystic ovary syndrome

Basit Öğe Kaydı
dc.contributor.authorHacivelioglu, Servet
dc.contributor.authorGungor, Ayse Nur Cakir
dc.contributor.authorGencer, Meryem
dc.contributor.authorUysal, Ahmet
dc.contributor.authorHizli, Deniz
dc.contributor.authorKoc, Evrim
dc.contributor.authorCosar, Emine
dc.date.accessioned2025-01-27T20:12:26Z
dc.date.available2025-01-27T20:12:26Z
dc.date.issued2013
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjective: To evaluate the association between acne, quantified by the Global Acne Grading System (GAGS), and abnormal clinical and laboratory markers of androgen excess in patients with polycystic ovary syndrome (PCOS). Methods: The retrospective study included 133 patients with PCOS. Acne severity was quantified with the GAGS score, alopecia was graded with the Ludwig classification, and hirsutism was quantified with a modified Ferriman-Gallwey (FG) score. Results: The mean GAGS score was significantly greater in younger women, those with a lower BMI, and those with a higher FG score. There was no relation between the mean GAGS score and waist circumference, waist/hip ratio, androgen hormone levels (free testosterone, total testosterone, or dehydroepiandrosterone sulfate), sex-hormone-binding globulin level, or menstrual irregularity. Alopecia was significantly associated with an increased waist/hip ratio; there was no relation between alopecia and age, waist circumference, body mass index, FG score, androgen hormone levels, or menstrual irregularity. A weak positive correlation was observed between the GAGS and FG scores. Conclusion: The GAGS may provide more precise and comprehensive information about acne severity in obese or hirsute patients with PCOS because this grading system includes evaluation of the type (comedones, papules, pustules, nodules) and location (anatomic area) of acne lesions. (c) 2013 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
dc.identifier.doi10.1016/j.ijgo.2013.05.005
dc.identifier.endpage36
dc.identifier.issn0020-7292
dc.identifier.issue1
dc.identifier.pmid23948280
dc.identifier.scopus2-s2.0-84884206600
dc.identifier.scopusqualityQ1
dc.identifier.startpage33
dc.identifier.urihttps://doi.org/10.1016/j.ijgo.2013.05.005
dc.identifier.urihttps://hdl.handle.net/20.500.12428/20941
dc.identifier.volume123
dc.identifier.wosWOS:000325122400009
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Ireland Ltd
dc.relation.ispartofInternational Journal of Gynecology & Obstetrics
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectAcne vulgaris
dc.subjectAlopecia
dc.subjectGynecology
dc.subjectHirsutism
dc.subjectHyperandrogenism
dc.subjectPolycystic Ovary Syndrome
dc.subjectTestosterone
dc.titleAcne severity and the Global Acne Grading System in polycystic ovary syndrome
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu